previous
unknown
coronaviru
caus
sever
acut
respiratori
syndrom
sarscov
affect
person
worldwid
respons
death
first
outbreak
reason
unknown
sar
viru
less
sever
clinic
progress
great
deal
milder
children
younger
year
age
contrast
mortal
rate
exceed
person
age
part
sinoeuropean
project
sar
diagnost
antivir
sepsda
immun
phagedisplay
librari
creat
convalesc
patient
phagemid
system
select
singlechain
fragment
variabl
scfv
antibodi
recogn
sarscov
februari
new
previous
unknown
deadli
coronaviru
caus
sever
acut
respiratori
syndrom
sarscov
brought
attent
world
health
organ
dr
carlo
urbani
colleagu
sar
viru
origin
provinc
guangdong
southern
china
novemb
initi
thought
caus
atyp
pneumonia
howev
within
short
time
viru
spread
hong
kong
singapor
vietnam
canada
unit
state
taiwan
sever
european
countri
concert
effort
scientif
commun
led
rapid
identif
novel
coronaviru
etiolog
agent
sar
full
genom
sequenc
viru
sarscov
genom
kb
length
contain
potenti
open
read
frame
orf
accord
sarscov
affect
individu
worldwid
respons
death
first
outbreak
reason
unknown
sar
viru
less
sever
clinic
progress
great
deal
milder
children
younger
year
age
contrast
mortal
rate
highest
among
patient
year
exceed
person
age
year
hong
kong
peopl
die
sar
mortal
rate
children
age
year
hand
case
person
older
year
show
histori
chronic
diseas
http
wwwhkuhkctcsar
hk
present
experiment
evid
explain
observ
age
distribut
howev
note
recent
discov
coronaviru
strain
exhibit
markedli
differ
age
distribut
regard
clinic
symptom
coronavirus
group
virus
crownlik
coron
appear
sarscov
positivestrand
rna
virus
virion
consist
nucleocapsid
core
encapsul
three
envelop
glycoprotein
spike
membran
envelop
e
protein
common
member
genu
rna
packag
nucleocapsid
n
protein
helic
nucleocapsid
sar
viru
n
protein
ident
known
coronavirus
suggest
major
immunogen
protein
known
major
target
cellular
immun
respons
play
import
role
initi
role
infect
continu
work
perform
find
earli
diagnosi
therapi
sar
sever
differ
approach
taken
diagnosi
perform
serolog
test
use
indirect
fluoresc
antibodi
enzymelink
immunosorb
assay
elisa
specif
sarscov
antibodi
detect
sarscov
done
use
clinic
specimen
serum
nasal
secret
stool
done
viral
isol
electron
microscopi
viral
cultur
revers
transcript
polymeras
chain
reaction
rtpcr
test
viral
rna
neutral
antibodi
nab
found
sar
viru
one
target
nab
glycoprotein
especi
toward
metallopeptidas
angiotensinconvert
enzym
bind
domain
nab
select
domain
within
sepsda
consortium
signific
progress
made
regard
structur
understand
sarscov
develop
put
therapi
increas
understand
viral
biolog
help
devis
novel
therapi
effort
harvest
protect
immun
gener
convalesc
patient
initi
antibodi
sar
protein
obtain
differ
way
commonli
use
hybridoma
make
monoclon
antibodi
immun
follow
collect
antiserum
select
use
phage
display
perform
select
scfv
antibodi
semisynthet
nonimmun
librari
immun
librari
first
time
fusion
protein
display
surfac
filament
bacteriophag
gp
smith
show
foreign
dna
fragment
could
insert
middl
gene
iii
creat
fusion
protein
phage
particl
display
protein
peptid
surfac
carri
gene
display
protein
peptid
insid
particl
give
linkag
phenotyp
genotyp
allow
select
phage
display
protein
peptid
affin
given
target
time
gene
encod
protein
peptid
coselect
way
possibl
screen
million
differ
display
protein
peptid
singlechain
antibodi
fragment
scfv
display
surfac
filament
bacteriophag
first
time
mccafferti
et
al
came
first
public
display
librari
fragment
antigenbind
fab
fragment
giiip
gviiip
subsequ
better
larger
librari
construct
use
select
antibodi
numer
differ
antigen
creation
larg
phagedisplay
librari
give
potenti
isol
human
antibodi
antigen
make
possibl
bypass
hybridoma
technolog
immun
addit
immun
system
involv
select
antibodi
phage
display
possibl
select
antibodi
toxic
compound
lethal
pathogen
highli
conserv
antigen
gener
two
kind
antibodi
librari
creat
donor
immun
nonimmun
librari
immun
librari
made
immunoglobulin
ig
variabl
region
v
gene
deriv
immun
donor
immun
librari
bias
toward
specif
antigen
lead
select
higheraffin
antibodi
compar
librari
size
librari
made
ig
v
gene
deriv
nonimmun
donor
synthet
vgene
librari
unbias
therefor
select
antibodi
virtual
antigen
creation
immun
phagedisplay
librari
immun
donor
shown
particular
effici
select
neutral
antibodi
nab
differ
virus
exampl
rabi
varicellazost
hepat
e
measl
respiratori
syncyti
viru
use
phage
display
seem
ideal
select
antibodi
sarscov
creat
immun
librari
base
peripher
blood
lymphocyt
convalesc
patient
phagemid
system
would
provid
possibl
develop
earli
diagnosi
therapi
sar
nab
select
earli
fast
diagnosi
still
import
anoth
outbreak
occur
domain
ntermin
residu
sarsassoci
coronaviru
protein
